The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance
Abstract
Background & aims High red and processed meat consumption is related to type 2 diabetes. In addition, cooking meat at high temperatures for a long duration forms heterocyclic amines (HCAs), which are related to oxidative stress. However, the association between meat consumption and non-alcoholic fatty liver disease (NAFLD) is yet to be thoroughly tested. Therefore, we aimed to test the association of meat type and cooking method with NAFLD and insulin resistance (IR).Methods This was a cross-sectional study in individuals who were 40-70 years old and underwent screening colonoscopy between 2013 and 2015 in a single center in Israel. NAFLD and IR were evaluated by ultrasonography and homeostasis model assessment. Meat type and cooking method were measured by a food frequency questionnaire (FFQ) and a detailed meat questionnaire. Unhealthy cooking methods were considered as frying and grilling to a level of well done and very well done. Dietary HCA intake was calculated.Results A total of 789 individuals had a valid FFQ and 357 had a valid meat questionnaire. High consumption of total meat (portions/day above the median) (odds ratio [OR] 1.49; 95% CI 1.05-2.13; p = 0.028; OR 1.63; 1.12-2.37; p = 0.011), red and/or processed meat (OR1.47; 95% CI 1.04-2.09; p = 0.031; OR1.55; 1.07-2.23; p = 0.020) was independently associated with higher odds of NAFLD and IR, respectively, when adjusted for: body mass index, physical activity, smoking, alcohol, energy, saturated fat and cholesterol intake. High intake of meat cooked using unhealthy methods (OR1.92; 95% CI 1.12-3.30; p = 0.018) and HCAs (OR2.22; 95% CI 1.28-3.86; p = 0.005) were independently associated with higher odds of IR.Conclusion High consumption of red and/or processed meat is associated with both NAFLD and IR. High HCA intake is associated with IR. If confirmed in prospective studies, limiting the consumption of unhealthy meat types and improving preparation methods may be considered as part of NAFLD lifestyle treatment.Lay summary High red and processed meat consumption is related to several diseases. In addition, cooking meat at high temperatures for a long duration forms heterocyclic amines, which have harmful health effects. Non-alcoholic fatty liver disease is a significant public health burden and its formation is strongly related to insulin resistance. In this study, both were found to be more frequent in people who consume relatively high quantities of red and processed meat. In addition, a high intake of heterocyclic amines was associated with insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several observational and crosssectional studies have shown the harmful association between MASLD and high intake of red and processed meat. 302 -304”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [303]
Citations
Cites
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Willett, W. C. (1998) · doi:10.1093/acprof:oso/9780195122978.001.0001 · Cited by 4,541
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
Estes, C., Razavi, H. A., Loomba, R. S., Younossi, Z. M., & Sanyal, A. J. (2017) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,496
Mozaffarian, D. (2016) · Circulation · doi:10.1161/circulationaha.115.018585 · Cited by 2,216
Carcinogenicity of consumption of red and processed meat
Bouvard, V., LOOMIS, D. P., Guyton, K. Z., Grosse, Y., Ghissassi, F. E., Benbrahim‐Tallaa, L., Guha, N., Mattock, H., & Straíf, K. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00444-1 · Cited by 1,918
Loomba, R. S., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,732
Brunt, E. M., Kleiner, D. E., Wilson, L. A., Belt, P., & Neuschwander-Tetri, B. A. (2011) · Hepatology · doi:10.1002/hep.24127 · Cited by 1,251
Micha, R., Wallace, S. K., & Mozaffarian, D. (2010) · Circulation · doi:10.1161/circulationaha.109.924977 · Cited by 1,244
Cited by
Sorted by citations
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Self-citationYounossi, Z. M., Corey, K. E., & Lim, J. K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.051 · Cited by 510
(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 545
Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade
Tilg, H., Adolph, T. E., & Moschen, A. R. (2020) · Hepatology · doi:10.1002/hep.31518 · Cited by 455
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Pafili, K., & Roden, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101122 · Cited by 330
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Yki-Järvinen, H., Luukkonen, P. K., Hodson, L., & Moore, J. B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00472-y · Cited by 294
Vilar‐Gomez, E., Nephew, L. D., Vuppalanchi, R., Gawrieh, S., Mladenovic, A., Pike, F., Samala, N., & Chalasani, N. (2022) · Hepatology · doi:10.1002/hep.32207 · Cited by 277
Non-alcoholic fatty liver disease: A patient guideline
Francque, S. M., Marchesini, G., Kautz, A., Walmsley, M., Dorner, R., Lazarus, J. V., Zelber-Sagi, S., Hallsworth, K., Busetto, L., Frühbeck, G., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100322 · Cited by 264
Self-citationThe role of nutrition in non‐alcoholic fatty liver disease: Pathophysiology and management
Berná, G., & Romero‐Gómez, M. (2020) · Liver International · doi:10.1111/liv.14360 · Cited by 235
Lujan, P. V., Esmel, E. V., & Sacanella, E. (2021) · Nutrients · doi:10.3390/nu13051442 · Cited by 225
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
Perdomo, C. M., Frühbeck, G., & Escalada, J. (2019) · Nutrients · doi:10.3390/nu11030677 · Cited by 222
Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD
Rinella, M. E., Tacke, F., Sanyal, A. J., & Anstee, Q. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.019 · Cited by 209
Ge, X.-J., Zheng, L., Wang, M., Du, Y., & Jiang, J. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036663 · Cited by 198
Paik, J. M., Henry, L. L., Younossi, Y., Ong, J. P., Alqahtani, S. A., & Younossi, Z. M. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000251 · Cited by 186
Diet and exercise in NAFLD/NASH: Beyond the obvious
Semmler, G., Datz, C., Reiberger, T., & Trauner, M. (2021) · Liver International · doi:10.1111/liv.15024 · Cited by 187
Technological, Regulatory, and Ethical Aspects of In Vitro Meat: A Future Slaughter‐Free Harvest
Bhat, Z. F., Morton, J. D., Mason, S. L., Bekhit, A. E. A., & Bhat, H. F. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12473 · Cited by 161
Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties
Allen, A. M., Lazarus, J. V., & Younossi, Z. M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.026 · Cited by 156
Noureddin, M., Zelber‐Sagi, S., Wilkens, L. R., Porcel, J., Boushey, C. J., Le Marchand, L., Rosen, H. R., & Setiawan, V. W. (2020) · Hepatology · doi:10.1002/hep.30967 · Cited by 148
Self-citationPathogenesis of NASH: the Impact of Multiple Pathways
Noureddin, M., & Sanyal, A. J. (2018) · Current Hepatology Reports · doi:10.1007/s11901-018-0425-7 · Cited by 135
Alferink, L. J. M., Jong, J. C. K., Erler, N. S., Veldt, B. J., Schoufour, J. D., de Knegt, R. J., Ikram, M. A., Metselaar, H. J., Janssen, H. L. A., Franco, O. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315940 · Cited by 130
Dhar, C., Sasmal, A., & Varki, A. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00807 · Cited by 127
Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD
Rinella, M. E., Tacke, F., Sanyal, A. J., Anstee, Q. M., & Workshop, O. B. O. T. P. O. T. A. (2019) · Hepatology · doi:10.1002/hep.30782 · Cited by 124
He, K., Li, Y., Guo, X., Zhong, L., & Tang, S. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520000914 · Cited by 113
Petermann-Rocha, F. E., Wirth, M. D., Boonpor, J., Parra-Soto, S. L., Zhou, Z., Mathers, J. C., Livingstone, K. M., Forrest, E. H., Pell, J. P., Ho, F. K. W., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02793-y · Cited by 106
Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.
Polyzos, S., Vachliotis, I. D., & Mantzoros, C. (2023) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2023.155676 · Cited by 83
Dietary patterns and risk of non-alcoholic fatty liver disease
Salehi‐Sahlabadi, A., Sadat, S., Beigrezaei, S., Pourmasomi, M., Feizi, A., Ghiasvand, R., Hadi, A., Clark, C. C. T., & Miraghajani, M. S. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01612-z · Cited by 92
Hydes, T., Ravi, S., Loomba, R. S., & Gray, M. E. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0067 · Cited by 90
Wajcman, D. I., Isakov, N. F., Webb, M., Bentov, I., Shibolet, O., Kariv, R., & Zelber‐Sagi, S. (2021) · Liver International · doi:10.1111/liv.14996 · Cited by 88
Self-citationMohammed, H. H. H., Jin, G., Ma, M., Khalifa, I., Shukat, R., Elkhedir, A. E. E., Zeng, Q., & Noman, A. E. (2019) · LWT · doi:10.1016/j.lwt.2019.108714 · Cited by 79
Guo, W., Ge, X., Lü, J., Xu, X. P., Gao, J., Wang, Q., Song, C., Zhang, Q., & Yu, C. (2022) · Nutrients · doi:10.3390/nu14245335 · Cited by 78
Consumption of processed red meat and its impact on human health: A review
Libera, J., Iłowiecka, K., & Stasiak, D. M. (2021) · International Journal of Food Science & Technology · doi:10.1111/ijfs.15270 · Cited by 80
Henney, A. E., Gillespie, C. S., Alam, U., Hydes, T. J., & Cuthbertson, D. J. (2023) · Nutrients · doi:10.3390/nu15102266 · Cited by 74
Zelber‐Sagi, S., Wajcman, D. I., Isakov, N. F., Hahn, M., Webb, M., Shibolet, O., Kariv, R., & Tirosh, O. (2020) · Antioxidants · doi:10.3390/antiox9070578 · Cited by 76
Self-citationDiet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding
Grant, W. B., & Blake, S. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230418 · Cited by 82
Biolato, M., Manca, F., Marrone, G., Cefalo, C., Racco, S., Miggiano, G. A. D., Valenza, V., Gasbarrini, A., Miele, L., & Grieco, A. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i4.509 · Cited by 78
Wajcman, D. I., Isakov, N. F., Salomone, F., Webb, M., Shibolet, O., Kariv, R., & Zelber‐Sagi, S. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.06.005 · Cited by 73
Self-citationSalomone, F., Wajcman, D. I., Isakov, N. F., Webb, M., Grosso, G., Godos, J., Galvano, F., Shibolet, O., Kariv, R., & Zelber‐Sagi, S. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100069 · Cited by 71
Self-citationProtein and amino acids in nonalcoholic fatty liver disease
Tricò, D., Biancalana, E., & Solini, A. (2020) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000706 · Cited by 70
Tsompanaki, E., Thanapirom, K., Papatheodoridi, Μ., Parikh, P. M., de Lima, Y. C., & Tsochatzis, E. A. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.11.026 · Cited by 76
Saeed, N., Nadeau, B., Shannon, C., & Tincopa, M. (2019) · Nutrients · doi:10.3390/nu11123064 · Cited by 65
Epidemiology of liver diseases: global disease burden and forecasted research trends
Xiao, J., Wang, F., Yuan, Y., Gao, J., Lu, X., Chao, Y., Guo, F., Zhong, J., Che, Z., Li, W., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2722-2 · Cited by 67
Parra-Vargas, M., Rodriguez‐Echevarría, R., & Jiménez‐Chillarón, J. C. (2020) · Nutrients · doi:10.3390/nu12123860 · Cited by 64
Lanthier, N., Rodriguez, J., Nachit, M., Hiel, S., Tréfois, P., Neyrinck, A. M., Cani, P. D., Bindels, L. B., Thissen, J., & Delzenne, N. M. (2021) · Scientific Reports · doi:10.1038/s41598-020-79718-9 · Cited by 66
Quan, W., Zeng, M., Ye, J., Li, Y., Xue, C., Liu, G., Wang, Z., Qin, F., He, Z., & Chen, J. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa184 · Cited by 65
Hashemian, M., Merat, S., Poustchi, H., Jafari, E., Radmard, A.-R., Kamangar, F., Freedman, N. D., Hekmatdoost, A., Sheikh, M., Boffetta, P., et al. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001229 · Cited by 57
Alferink, L. J. M., Erler, N. S., de Knegt, R. J., Janssen, H. L. A., Metselaar, H. J., Murad, S. D., & Jong, J. C. K. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00627-2 · Cited by 56
Samraj, A. N., Bertrand, K. A., Luben, R., Khedri, Z., Yu, H., Nguyen, D., Gregg, C. J., Diaz, S. L., Sawyer, S. J., Chen, X., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197464 · Cited by 58
Dietary fiber intake and non-alcoholic fatty liver disease: The mediating role of obesity
Zhu, Y., Hu, Y., Zhang, Y., Rao, S., Mo, Y., Zhang, H., Liang, S., Zhang, Z., & Yang, W. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1038435 · Cited by 53
Kim, M. N., Lo, C.-H., Corey, K. E., Luo, X., Long, L., Zhang, X., Chan, A. T., & Simon, T. G. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.12.014 · Cited by 51
MASLD treatment—a shift in the paradigm is imminent
Machado, M. V. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1316284 · Cited by 51
One size does not fit all; practical, personal tailoring of the diet to NAFLD patients
Zelber‐Sagi, S., Grinshpan, L. S., Ivancovsky‐Wajcman, D., Goldenshluger, A., & Gepner, Y. (2022) · Liver International · doi:10.1111/liv.15335 · Cited by 49
Self-citationHigh Protein Intake Is Associated With Histological Disease Activity in Patients With NAFLD
Lang, S., Martin, A., Farowski, F., Wisplinghoff, H., Vehreschild, M. J. G. T., Liu, J., Krawczyk, M. J., Nowag, A., Kretzschmar, A., Herweg, J., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1509 · Cited by 49
Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
Wijarnpreecha, K., Aby, E. S., Ahmed, A., & Kim, D. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0239 · Cited by 52
Forlano, R., Mullish, B. H., Roberts, L. A., Thursz, M. R., & Manousou, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020662 · Cited by 52
Zheng, J., Zhao, L., Dong, J., Chen, H., Li, D., Zhang, X., Hassan, M. M., Steck, S. E., Li, X., Xiang, Y., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.08.018 · Cited by 48
Wu, J., Zeng, C., Yang, Z., Li, X., Lei, G., Xie, D., Wang, Y., Wei, J., & Yang, T. (2019) · Journal of the American College of Nutrition · doi:10.1080/07315724.2019.1613271 · Cited by 46
Bullón‐Vela, V., Abete, I., Tur, J. A., Pintó, X., Corbella, E., Martínez‐González, M. Á., Toledo, E., Corella, D., Macías, M., Tinahones, F. J., et al. (2019) · Nutrition · doi:10.1016/j.nut.2019.110620 · Cited by 46
Cervo, A., Shengir, M., Patel, K., & Sebastiani, G. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00531-0 · Cited by 46
Zhang, R., Fu, J., Moore, J. B., Stoner, L. R., & Li, R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010788 · Cited by 49
Geng, Y., Xie, Y., Li, W., Ji, J., Chen, F., Liao, X., Hu, X., & Ma, L. (2023) · Food Reviews International · doi:10.1080/87559129.2023.2221346 · Cited by 44
Song, D., Li, C., Wang, Z., Zhao, Y., Shen, B., & Zhao, W. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13489 · Cited by 47
Konieczna, J., Fiol, M., Colom, A., Martínez‐González, M. Á., Salas‐Salvadó, J., Corella, D., Soria-Florido, M. T., Martínez, J. A., Alonso‐Gómez, Á. M., Wärnberǵ, J., et al. (2022) · Nutrients · doi:10.3390/nu14194142 · Cited by 47
An overview of the cholesterol metabolism and its proinflammatory role in the development of MASLD
Zhang, L., Shi, Y., Liang, B., & Li, X. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000434 · Cited by 49
Towards Win–Win Policies for Healthy and Sustainable Diets in Switzerland
Ernstoff, A. S., Stylianou, K. S., Sahakian, M., Godin, L., Dauriat, A., Humbert, S., Erkman, S., & Jolliet, O. (2020) · Nutrients · doi:10.3390/nu12092745 · Cited by 45
Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives
Clayton‐Chubb, D., Kemp, W. W., Majeed, A., Lubel, J. S., Hodge, A., & Roberts, S. K. (2023) · Nutrients · doi:10.3390/nu15030687 · Cited by 45
Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
Semmler, G., Datz, C., & Trauner, M. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0364 · Cited by 43
Montemayor, S., García, S., Monserrat-Mesquida, M., Tur, J. A., & Bouzas, C. (2023) · Nutrients · doi:10.3390/nu15183987 · Cited by 43
Du, S., Sullivan, V. K., Fang, M., Appel, L. J., Selvin, E., & Rebholz, C. M. (2024) · Diabetologia · doi:10.1007/s00125-024-06221-5 · Cited by 45
Chen, J., Bian, D., Zang, S., Yang, Z., Tian, G., Luo, Y., Yang, J., Xu, B., & Shi, J. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1580143 · Cited by 41
Kamada, Y., Takahashi, H., Shimizu, M., Kawaguchi, T., Sumida, Y., Fujii, H., Seko, Y., Fukunishi, S., Tokushige, K., Nakajima, A., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01833-9 · Cited by 43
Wajcman, D. I., Isakov, N. F., Grinshpan, L. S., Salomone, F., Lazarus, J. V., Webb, M., Shibolet, O., Kariv, R., & Zelber‐Sagi, S. (2022) · Nutrients · doi:10.3390/nu14173533 · Cited by 39
Self-citationBeyond the Liver: Liver-Eye Communication in Clinical and Experimental Aspects
Yuan, T.-H., Yue, Z., Zhang, G.-H., Wang, L., & Dou, G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.823277 · Cited by 39
Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis
Tabaeian, S. P., Rezapour, A., Azari, S., Martini, M., Saran, M., Behzadifar, M., Shahabi, S., Sayyad, A., Tahernejad, A., Bragazzi, N. L., et al. (2023) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2023.06.009 · Cited by 38
Ahmad, M. I., Zou, X., Ijaz, M. U., Hussain, M., Liu, C., Xu, X., Zhou, G., & Li, C. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03136 · Cited by 39
Rooholahzadegan, F., Arefhosseini, S., Tutunchi, H., Badali, T., Khoshbaten, M., & Ebrahimi‐Mameghani, M. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00733-4 · Cited by 37
Hadefi, A., Arvanitakis, M., Trépo, E., & Zelber‐Sagi, S. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12443 · Cited by 40
Self-citationPractical Lifestyle Management of Nonalcoholic Fatty Liver Disease for Busy Clinicians
Zelber‐Sagi, S., & Moore, J. B. (2024) · Diabetes Spectrum · doi:10.2337/dsi23-0009 · Cited by 39
Self-citationSualeheen, A., Tan, S., Georgousopoulou, E. N., Daly, R. M., Tierney, A. C., Roberts, S. K., & George, E. S. (2024) · Nutrition Bulletin · doi:10.1111/nbu.12707 · Cited by 39
Food groups in dietary prevention of type 2 diabetes
Basiak-Rasała, A., Różańska, D., & Zatońska, K. (2019) · Roczniki Państwowego Zakładu Higieny · doi:10.32394/rpzh.2019.0086 · Cited by 37
Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
Zelber‐Sagi, S., Noureddin, M., & Shibolet, O. (2021) · Cancers · doi:10.3390/cancers14010103 · Cited by 33
Self-citationPan, X.-T., Xie, X.-X., Peng, H.-W., Cai, X.-L., Li, H.-Q., Hong, Q.-Z., Wu, Y.-L., Lin, X., Xu, S., & Peng, X.-E. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00220 · Cited by 23
Han, M. A. T., Yu, Q., Tafesh, Z., & Pyrsopoulos, N. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00082 · Cited by 33
Nutrition as Therapy in Liver Disease.
Shah, N., & Barritt, A. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.04.012 · Cited by 24
Deciphering the role of aberrant DNA methylation in NAFLD and NASH
Vachher, M., Bansal, S., Kumar, B., Yadav, S., & Burman, A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11119 · Cited by 33
Valenzuela, R., Farías, C., Muñoz, Y., Zúñiga‐Hernández, J., & Videla, L. A. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112676 · Cited by 36
Consumption of Ultra-Processed Food and Cognitive Decline among Older Adults With Type-2 Diabetes
Weinstein, G., Vered, S., Wajcman, D. I., Ravona‐Springer, R., Heymann, A. D., Zelber‐Sagi, S., Shahar, D. R., & Beeri, M. S. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac070 · Cited by 32
Self-citationAhmad, M. I., Ijaz, M. U., Hussain, M., Khan, I. A., Mehmood, N., Siddiqi, S. M., Liu, C., Zhao, D., Xu, X., Zhou, G., et al. (2019) · Food & Function · doi:10.1039/c9fo02207d · Cited by 27
Armandi, A., & Schattenberg, J. M. (2021) · Nutrients · doi:10.3390/nu13061977 · Cited by 28
Kord‐Varkaneh, H., Poursoleiman, F., Masri, M. K. A., Alras, K. A., Shayah, Y., Masmoum, M. D., Alangari, F. A., Alras, A., Rinaldi, G., Day, A. S., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.987921 · Cited by 29
Peng, H., Xie, X., Pan, X., Zheng, J., Zeng, Y., Cai, X., Hu, Z., & Peng, X. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01688-7 · Cited by 27
Non-alcoholic fatty liver disease: Current therapeutic options
Majumdar, A., Verbeek, J., & Tsochatzis, E. A. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.09.007 · Cited by 26
Kim, Y., Shin, D., Yune, J. H., Jung, H.-S., Kwon, H.-C., Lee, K.-W., Oh, J., Kim, B. G., & Han, S. G. (2022) · Gels · doi:10.3390/gels8060369 · Cited by 25
Zhong, L., Guo, X., Xue, H., Qiao, Y., Mao, D., Ye, X., Cui, Z., Li, Z., Hu, G., & Huang, Y. (2023) · Foods · doi:10.3390/foods12132486 · Cited by 25
Willmann, C., Heni, M., Linder, K., Wagner, R. J., Stefan, N., Machann, J., Schulze, M. B., Joost, H., Häring, H., & Fritsche, A. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy307 · Cited by 27
Lara, C., & Romero‐Gómez, M. (2024) · European Cardiology Review · doi:10.15420/ecr.2023.34 · Cited by 22
Recaredo, G., Marín-Alejandre, B. A., Cantero, I., Monreal, J. I., Herrero, J. I., Benito, A., Elorz, M., Tur, J. A., Martínez, J. A., Zulet, M. Á., et al. (2019) · Nutrients · doi:10.3390/nu11102359 · Cited by 24
Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations
Zelber‐Sagi, S. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1729971 · Cited by 23
Self-citationCharatcharoenwitthaya, P., Tansakul, E., Chaiyasoot, K., Bandidniyamanon, W., & Charatcharoenwitthaya, N. (2021) · Nutrients · doi:10.3390/nu13124438 · Cited by 25
Aimuzi, R., Xie, Z., Qu, Y., Jiang, Y., & Luo, K. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114720 · Cited by 23
Zhang, Y., Qiao, W., Zhuang, J., Feng, H., Zhang, Z., & Zhang, Y. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100352 · Cited by 31
Metadata
- Authors
- Zelber-Sagi, S., Ivancovsky-Wajcman, D., Fliss Isakov, N., Webb, M., Orenstein, D., Shibolet, O., & Kariv, R.
- Affiliations
- Tel Aviv University (IL)
- University of Haifa (IL)
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 68
- Issue
- 6
- Pages
- 1239-1246
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2794354514
- Cited by
- 297
- References
- 62
- Citations by year
- 2026: 19 · 2025: 35 · 2024: 38 · 2023: 54 · 2022: 44 · 2021: 33 · 2020: 38 · 2019: 29 · 2018: 6
- FWCI
- 26.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- red meat consumption, processed meat consumption, non-alcoholic fatty liver disease, insulin resistance, heterocyclic amines, meat cooking methods, oxidative stress, meat consumption, type 2 diabetes risk, middle-aged and older adults, dietary exposure assessment
- MeSH terms
- Red Meat, Adult, Aged, Amines, Cooking, Cross-Sectional Studies, Eating, Female, Heterocyclic Compounds, Humans, Insulin Resistance, Israel, Male, Meat Products, Middle Aged, Surveys and Questionnaires, Risk Factors, Multivariate Analysis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review